The serotonin (5-hydroxytryptamine, or 5-HT) type 1A receptor (5-HT 1A R) is implicated in the pathophysiology of numerous neuropsychiatric disorders. We have published the initial evaluation and reproducibility in vivo of [O-methyl-11 C]2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5 (2H,4H)dione ( 11 C-CUMI-101), a novel 5-HT 1A agonist radiotracer, in Papio anubis. Here, we report the optimal modeling parameters of 11 C-CUMI-101 for human PET studies. Methods: PET scans were obtained for 7 adult human volunteers. 11 C-CUMI-101 was injected as an intravenous bolus, and emission data were collected for 120 min in 3-dimensional mode. We evaluated 10 different models using metabolite-corrected arterial input functions or reference region approaches and several outcome measures. Results: When using binding potential (BP F 5 B avail /K D [total available receptor concentration divided by the equilibrium dissociation constant]) as the outcome measure, the likelihood estimation in the graphical analysis (LEGA) model performed slightly better than the other methods evaluated at full scan duration. The average test-retest percentage difference was 9.90% 6 5.60%. When using BP ND (BP ND 5 f nd · B avail /K D ; BP ND equals the product of BP F and f nd [free fraction in the nondisplaceable compartment]), the simplified reference tissue method (SRTM) achieved the lowest percentage difference and smallest bias when compared with nondisplaceable binding potential obtained from LEGA using the metabolitecorrected plasma input function (r 2 5 0.99; slope 5 0.92). The time-stability analysis indicates that a 120-min scan is sufficient for the stable estimation of outcome measures. Voxel results were comparable to region-of-interest-based analysis, with higher spatial resolution. Conclusion: On the basis of its measurable and stable free fraction, high affinity and selectivity, good blood-brain barrier permeability, and plasma and brain kinetics, 11 C-CUMI-101 is suitable for the imaging of high-affinity 5-HT 1A binding in humans.
The serotonergic system and the serotonin (5-hydroxytryptamine, or 5-HT) type 1A receptor (5-HT 1A R) are implicated in psychiatric disorders and the action of antidepressants (1) (2) (3) (4) (5) (6) (7) (8) . Positron emission tomography (PET) radiotracers allow in vivo quantification of 5-HT 1A R binding.
G-protein-coupled receptors exist in a high-agonist-affinity state that is bound to G-proteins and a low-affinity state (uncoupled from G-protein) (9, 10) . Antagonists bind to either state with equal affinity, and existing PET radiotracers for this receptor are antagonists. Additionally, agonist radiotracers are more likely to be sensitive to changes in intrasynaptic concentrations of the neurotransmitter (11) , as demonstrated in the dopaminergic system (12) . [O-methyl- 11 C] 2-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)dione ( 11 C-CUMI-101), a new agonist radioligand (13) , has a measurable free fraction and highly reproducible binding potential (BP F ) in Papio anubis (14) .
We evaluate several modeling methods for quantifying 11 C-CUMI-101 binding in humans using a test-retest paradigm. We consider estimation of BP F (B avail /K D [total available receptor concentration divided by the equilibrium dissociation constant]), the closest approximation to B avail , at 6 different scanning durations.
MATERIALS AND METHODS
The study was approved by the Institutional Review Board, and participants gave written informed consent. Ten healthy volunteers signed an informed consent form, and 7 (3 women, 4 men; mean age 6 SD, 32 6 7 y) completed the study and were included in the analysis.
Radiochemistry
11 C-CUMI-101 was synthesized as previously described (13, 14) . The chemical purity of 11 C-CUMI-101 was 99.4% 6 2.3%, and the radiochemical purity was 99.4% 6 0.6%.
PET Studies
The PET procedure is described elsewhere (15) (16) (17) . Polyurethane head molds minimized motion (Soule Medical). An ECAT HR1 scanner was used (Siemens/CTI). 11 
Input Function Measurement
The measurement of input function has been described elsewhere (15) (16) (17) . Briefly, arterial samples were collected every 10 s in the first 2 min and less frequently thereafter, centrifuged, and plasma-separated. After initial extraction, the percentage of 11 C-CUMI-101 radioactivity in plasma was determined by highperformance liquid chromatography (13) . These fractions were then plotted and fit with a Hill's function (18) . The product of the unmetabolized fraction and the total plasma counts was fit with a second-order polynomial from time zero to the plasma peak and the sum of 3 exponentials from the peak to the end. The mean free fraction (16) was 0.30 6 0.03.
Image Analysis
Using a 3-T Signa HDx system (GE Healthcare), we acquired T1-weighted MR images (3-dimensional fast spoiled gradientrecalled echo) for coregistration with PET images and identified regions of interest (ROIs) (17) . Subject motion was corrected by coregistering each PET frame to frame 8, using FLIRT (FMRIB linear image registration tool, version 5.0; FMRIB Image Analysis Group). After attenuation correction, PET-to-MRI transformations were computed using FLIRT with a mutual information cost function and 6 degrees of freedom. Eight different coregistration possibilities, with varying source or target images and weighting masks, were performed, as previously described (19) . The optimum transformation was applied to the average PET image and all PET frames. Images were resliced in FLIRT with trilinear interpolation, and the results were verified by visual inspection.
Automatic ROIs were obtained for all regions except the raphe, which was manually drawn on the subject's PET image. The algorithm assigns probabilistic ROIs to an MR image using an automated multilabel approach, in which the ROIs from each of 18 templates, after being gray-matter-masked, are nonlinearly transformed to the MR image. The 18 templates were created using 18 healthy subjects' MRI brain scans. ROIs were hand-drawn on each template MR image by experienced technicians trained to reliably approximate these regions using brain atlases (20, 21) and published reports (22, 23) . Before the templates were applied to study subjects, each subject's MR image was preprocessed with Freesurfer (http://surfer.nmr.mgh.harvard.edu/), and the bias-corrected and intensity-normalized results were used in conjunction with gray matter, white matter, and cerebrospinal fluid maps derived with SPM5 (Wellcome Department of Cognitive Neurology) to remove nonbrain areas. Each of the 18 template MR images was then nonlinearly registered with the Automated Registration Toolbox (24) to the target subject's brain (25) . To calculate the probability of an ROI label for a particular voxel, the total number of transformed template ROIs assigned to that voxel was counted and divided by 18. Cortical regions were then graymatter-masked using the target subject's segmentation. This masking was done for each ROI separately and for each voxel to establish a probabilistic set of ROIs in target subject space for use in PET analysis. For the 7 subjects, the average sizes (in cm 3 ) of the automatically delineated regions, from largest to smallest, were 192.5 6 14.7 (parietal lobe), 160.1 6 12.7 (occipital lobe), 148.8 6 14.2 (temporal lobe), 146.5 6 7.0 (dorsolateral prefrontal cortex), 90.2 6 5.8 (orbital prefrontal cortex), 63.8 6 5.8 (cerebellar gray matter), 59.5 6 4.0 (medial prefrontal cortex), 31.7 6 2.5 (cingulate), 21.0 6 1.4 (insula), 18.7 6 1.5 (hippocampus), 17.1 6 1.6 (entorhinal cortex), 11.6 6 0.7 (posterior parahippocampal gyrus), and 10.6 6 0.8 (amygdala). The V T derived from probabilistic ROIs used in this analysis was correlated with corresponding hand-drawn ROIs for 11 C-WAY-100635 and 11 C-DASB (n 5 30; r 2 . 0.98).
Modeling
Modeling approaches can be divided into 2 major categories: kinetic and graphical (14) (15) (16) (17) . The 2-tissue-compartment (2TC) kinetic model uses a standard iterative nonlinear least squares algorithm for constrained (where the ratio of K 1 /k 2 is constrained to the value of the reference region's [RR's] V T ) and unconstrained approaches. For the noniterative approach (26) (2TCNI), the time-activity curve is regressed on each of a library of functions. Likelihood estimation in graphical analysis (LEGA) (27, 28) is a bias-free alternative to graphical analysis (29) , using the last 8 time points for fitting. One-tissue-compartment and 3-tissuecompartment models proved to be unreliable and overparameterized and are not presented.
Three methods not requiring blood sampling were evaluated: the simplified reference tissue model (SRTM) (30) and bloodless versions of Logan analysis and LEGA. These methods used the gray matter of the cerebellum (CGM, obtained by applying an SPM5-derived gray-matter mask to the cerebellum) as an RR.
All modeling methods were applied to the time-activity curve data using a 5% blood volume correction. Weights (w i ) were assigned to each frame according to w 5 ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffi t i À t iÀ1 p ; where t i is the mid-time of the current frame and t i 2 1 is the mid-time of the previous frame.
Six metrics were used to compare the models: percentage difference (PD) and within-subject mean sum of squares (WSMSS) for reproducibility, percentage SD (%SD) of BP F , intraclass correlation coefficient (ICC) for reliability, median absolute deviation of bootstrap resampled data for identifiability, and time stability Mean 6 SD across all subjects and all regions is shown. Models that attain best mean result in each category are in bold.
(TS). Each of these has been described before (14) (15) (16) (17) , with the exception of %SD. The %SD of an outcome measure is the SD of the sample (across experiments) divided by the sample mean.
For the RR techniques, the percentage bias was also calculated as ð1003BP is BP ND calculated using the RR approach.
Voxel-Level Analysis
V T parametric images were obtained by applying empirical Bayesian estimation in graphical analysis (EBEGA) (31), a fully automatic approach that incorporates LEGA (28) V T estimation in a Bayesian framework. The bloodless version of the Logan method was also considered for the generation of BP ND parametric images.
RESULTS
The uptake of 11 C-CUMI-101 is consistent with the known distribution of 5-HT 1A Rs ( Fig. 1 ; Table 1 ).
Modeling Figure 2 shows a representative hippocampal timeactivity curve. 2TC methods fit the data well; iterative and noniterative 1-tissue-compartment models do not and are excluded from further analysis. Logan analysis and LEGA produce similar fits (Fig. 2, right) .
Although the measure of interest is B avail , the closest measure of receptor density that can be estimated using PET is BP F (B avail /K D ), because 1/K D cannot be determined. Metric comparisons and TS analysis are performed on BP F .
Logan analysis and LEGA are the best performers in most metrics (Table 2) .
Although LEGA performs slightly better than do the other methods, the outcome metric comparisons are not strongly sensitive to model choice. Most models tested perform similarly; metric results in a single category fall within 1 SD. For all high-binding ROIs ( For completeness, the comparisons performed in Table 2 were repeated using the ratio (at equilibrium) of specifically bound radioligand to that of total parent radioligand in plasma (BP P 5 f P * B avail /K D ) in Table 3 . Though the metrics are different, the relative performance of each of the models is similar. Table 2 shows average metrics across all subjects and all ROIs. However, B avail , hence required scan duration, may vary with each ROI (Table 1) .
Most ROIs achieve less than 10% difference between test and retest, on average, and the lower-binding ROIs generally attain lower WSMSS and lower average identifiability values than the higher-binding ROIs (Table 1) .
Because both free fraction and binding in the RR will affect the estimation of BP F , outcome measures and metrics calculated using V T (Table 4 ) are presented.
Rate constants are important for assessing ligand kinetics and are presented in Table 5 .
Time Stability
TS was analyzed to determine the optimal scan duration. In aggregate, BP F was not stable before 110 min (Fig. 3) .
In several ROIs, BP F values calculated using 110 min of scan data were within 65% of those calculated using the full 120 min of data (Table 6 ). For other ROIs, 71% or more of the studies yielded stable BP F values at 110 min of scan time. The TS analysis was also repeated for V T . Except for 3 ROIs, V T values were stable at 110 min of scan time, suggesting that shorter scans may be possible, depending on the application and the target ROI. V T values converge faster than BP F values (Table 6 ). On average, V T values were within 8% of their terminal values from 70 min. 
RR Approaches
The 3 RR models produce BP ND values lower than those from LEGA with a plasma input function (Fig. 4) . Slopes of the regression lines predicting bloodless model outcomes from those calculated using LEGA with plasma input are 0.81, 0.86, and 0.92 for bloodless versions of Logan analysis and LEGA and SRTM, respectively. The intercepts range from 0.04 to 0.11.
The mean PD over all high-binding ROIs yields similar results across RR approaches using BP ND (Table 7) . However, SRTM was the best performer in almost all metrics.
The TS was also analyzed using RR approaches. At 110 min of scan time, 95.05% 6 8.93% of the SRTM results were stable, on average. Bloodless Logan analysis and LEGA results at 110 min were both less than 80% stable. When SRTM BP ND values at 110 min were regressed against BP ND values calculated using LEGA and 120 min of scan time, the results were similar to those in Figure 4 (slope 5 0.91, intercept 5 0.05, and R 2 5 0.99). Metric comparisons calculated using SRTM at 110 min did not vary greatly from those presented for SRTM (with 120 min) in Table  7 (9.98% 6 11.82%, 0.008 6 0.003, 0.64 6 0.16, 15.57% 6 5.60%, and 23.83% 6 4.56% for mean PD, WSMSS, ICC, percentage SD, and percentage bias, respectively).
Voxel Analysis
Modeling kinetic parameters on a voxel level, as opposed to an ROI level, provides greater spatial resolution. On an ROI level, LEGA has been proven to be a reliable modeling method. However, on voxel level, the added variance results in noisy outcome measure estimates. Thus, EBEGA was applied on a voxel level (31) . Similarly, although SRTM was found to be the optimal RR approach for ROI analysis, on a voxel level it was computationally expensive and pro- Entorhinal cortex  36  50  50  57  43  71  50  64  86  86  100  100  Hippocampus  29  43  57  64  57  64  57  71  79  100  100  100  Insula  43  43  57  71  86  86  86  86  100  100  100  100  Posterior parahippocampal gyrus  36  29  50  64  57  71  64  79  79  93  100  100  Temporal lobe  50  64  43  57  64  71  71  86  93  100  100  100  Amygdala  36  50  43  57  43  71  43  71  79  93  100  100  Cingulate  64  64  57  79  71  86  71  100  100  100  100  100  Medial prefrontal cortex  64  64  71  71  71  79  71  100  100  100  100  100  Orbital prefrontal cortex  50  57  50  79  57  71  57  86  79  100  100 For each region, percentages of BP F or V T (of 14 PET scans) are indicated; values are estimated using indicated scan lengths, which fall within 65% of BP F or V T values estimated using 120-min scan. duced many outliers. Therefore, an RR Logan approach was applied to produce BP ND images, despite its noisedependent bias (32) .
To determine whether these voxel-based methods could accurately estimate outcome measures, V T (or BP ND ) measurements of the high-binding regions calculated using LEGA on an ROI level were compared with those averaged within an ROI from EBEGA V T voxel images (or reference tissue Logan BP ND images; Fig. 5 ).The voxel-based region V T values obtained using EBEGA were generally lower than their ROI-based counterparts (slope 5 0.89; R 2 5 0.93). With BP F and BP P , slopes were the same and the intercept was 0.79 and 0.84, respectively. The Logan voxel method resulted in BP ND values that were approximately half those of their ROI counterparts (slope 5 0.58; R 2 5 0.80).
DISCUSSION
The goal of this study was to identify the optimal modeling method for 11 C-CUMI-101 in humans. As before, in Papio anubis (14) , this goal was accomplished by assessing outcome measures (BP F or BP ND ) from 10 modeling approaches on test-retest data, using 6 metrics to evaluate their performance across 6 different scan durations. This analysis was performed with ROIs derived by an automated approach, using metabolite-corrected arterial input function and reference tissue methods, with both ROI-and voxelbased modeling techniques.
Model Selection
At 120 min, the LEGA approach, using BP F or BP P , achieved the lowest percentage SD and best identifiability while attaining values in other categories indistinguishable from those of the other models. In addition, LEGA, using BP F , achieved the best ICC. Because BP F is proportional to BP P , the metric comparisons for both BP F and BP P are similar. The main differences are in the values of WSMSS and identifiability, which are significantly lower in the BP P calculation because the BP P values themselves are lower. Importantly, all the models with input functions (Table 2) performed similarly; outcome metrics were close to each other, and BP F estimates from differing models correlated highly. More than 90% of the V T estimates for 5 of the lower binding regions were stable after 100 min of scan time (Table 6 ), and average V T values of the highest binding regions were within 8% of their 120-min values from 70 min on (Fig. 6 ). Therefore, it may be possible to use shorter scan durations if V T is the outcome measure of interest.
RR Methods
Consistent with earlier findings (33) , all the bloodless modeling approaches yielded BP ND with negative bias, compared with the LEGA method with metabolite-corrected arterial input function (Table 7 ; Fig. 4 ). Among the bloodless methods, SRTM was the most highly reproducible, although the differences were small ( Table 7) .
The distribution volume of nondisplaceable compartment relative to total concentration of ligand in plasma (V ND ) of 11 C-CUMI-101 is higher than that of 11 C-WAY-100635, a commonly used antagonist 5-HT 1A tracer. Higher V ND is important because BP ND , the outcome measure of these reference tissue models, is calculated as BP ND 5 (V T 2 V ND )/V ND . It has been shown that cerebellar white matter is the most appropriate RR for 11 C-WAY-100635 studies, because it provides the closest approximation to nonspecific Mean 6 SD across all subjects and all regions is shown. Models that attain best average result in each category are in bold. binding for that tracer (34) . The average 11 C-WAY-100635 cerebellar white matter V T is 0.29 mL/cm 3 , and the average CGM V T is 0.47 mL/cm 3 . Because regional 11 C-WAY-100635 V T values vary from 27.73 mL/cm 3 (in the occipital lobe) to 64.92 mL/cm 3 (in the hippocampus), BP ND could be underestimated (using the CGM instead of cerebellar white matter as the RR) by approximately 38%. On the other hand, the average CGM V T for 11 C-CUMI-101 is 5.77 mL/cm 3 . Because 11 C-CUMI-101 binds only to the high-affinity 5-HT 1A Rs, specific binding is approximately half that of 11 C-WAY-100635 (0.09 mL/cm 3 in the cerebellum). Regional 11 C-CUMI-101 V T varies from 8.7 mL/cm 3 (in the occipital lobe) to 15.41 mL/cm 3 (in the entorhinal cortex). Because the amount of specific binding, compared with the total binding, within the cerebellum is so low, underestimation error in these regions varies between 2.4% and 4.4%.
Voxel-Based Analysis
Voxel-based analysis is a potentially valuable method because it increases the spatial resolution of the results-an important outcome because most anatomic structures in the brain are not necessarily functionally homogeneous. The cost of this increased resolution is increased noise. On the ROI level, the LEGA approach proved to be most reliable. However, on the voxel level, LEGA does not perform well; therefore, when using an arterial input function, EBEGA was employed (31) . EBEGA outperforms the other voxel-based methods tested in this study by yielding fewer outliers and producing the highest correlation with the least bias when compared with the winning ROI-based method.
Limitations and Other Considerations
In the current series of studies, test-retest scans were obtained on the same day from each subject. How sensitive 11 C-CUMI101 may be to displacement from binding by endogenous 5-HT in humans remains a question. We know from animal experiments that 11 C-CUMI101 can be displaced from binding by endogenous 5-HT in response to a substantial pharmacologic challenge (35) .
It has been shown that antagonist 1A binding correlates with age, sex, lifetime aggression, and C1019G polymorphism of the 5-HT 1A gene promotor region (5, 36) . We have not attempted to control for these variables because they are unimportant in a within-subject comparison design such as the one presented in the current work.
In addition, the RR used in this work was the CGM. Although outcome measures calculated using this RR were highly reproducible, validating the use of the CGM as an appropriate RR will require further experiments (binding in the CGM can be evaluated before and after administration of pindolol).
For the graphical approaches, only the last 8 time points, corresponding to minutes 40 through 120, were used for the model fitting. Because the kinetic approaches use the full time series of the time-activity curve data, which contain many more data points, comparison of some outcome metrics between kinetic and graphical approaches may be somewhat unfair. This is especially true for the identifiability measure, which-in the case of the graphical approachesis based on only 8 points and is thus a limitation of the model comparisons. However, as indicated by the similarity of outcome metrics across all modeling techniques, the results were not strongly sensitive to model choice or number of data points used. In addition, the quantitative model metric comparison was used as a guide in model selection. Model results were also visually inspected and compared.
Another possible limitation is the fact that the CGM RR could not be adequately fitted with a 1-tissue-compartment model. A cluster analysis was performed (data not shown) in an attempt to find any contiguous volume of voxels, the time-activity curve of which may be adequately fitted with a 1-tissue-compartment model. The fact that no such volume was found may be due to specific binding, partialvolume effect, radioactive metabolites in the brain (unlikely, because all metabolites are more polar), or significant, unequal nonspecific binding to 2 different targets.
CONCLUSION
Ten different modeling techniques were tested using 6 metrics and a TS analysis. In humans, at full scan duration the LEGA model yielded slightly better performance than the other methods presented. The reference tissue methods performed similarly on the metrics. When full quantification was used with arterial input function, this study indicates that a 120-min scan is advisable for the accurate estimation of BP F .
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